HPR157 Repurposed Drugs Launched Under the AMNOG in Germany: Effects on Benefit Assessment and Price Development

Autor:	SM Sake, A Martyniszyn-Eiben, E Zavatta, M Glüsen, I Berger, M Schönermark
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S261
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2701419aef0eda8d78404027c90fd17c https://doi.org/10.1016/j.jval.2022.09.1286 Zobrazit plný text záznamu Full Text from ScienceDirect